GULP, also known as engulfment and cell motility protein 1 (ELMO1), is a protein associated with the process of phagocytosis, which is the engulfment and removal of dead or dying cells by phagocytes. The PTB (phosphotyrosine-binding) domain-containing engulfment adaptor 1, or GULP, is implicated in mediating signal transduction pathways that regulate cellular engulfment processes. The activation of GULP is critical for the proper execution of phagocytosis, a fundamental cellular mechanism involved in tissue homeostasis, development, and immune response. This protein's PTB domain serves as a molecular interface for protein-protein interactions, facilitating the recruitment of signaling molecules to the phagocytic cup during engulfment events.
Research in this field often focuses on understanding the molecular mechanisms and regulatory factors that modulate the activation of GULP and its subsequent involvement in phagocytosis. The identification and characterization of GULP activators contribute to our knowledge of the intricate signaling cascades that govern cellular processes, shedding light on the broader context of cell clearance and immune function. Further studies may uncover the physiological relevance and implications of GULP activation in various cellular contexts, providing valuable insights into the dynamic nature of cell biology and its impact on organismal health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(Z)-4-Hydroxytamoxifen | 68047-06-3 | sc-3542C sc-3542 sc-3542B sc-3542A sc-3542D sc-3542E | 1 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $220.00 $281.00 $408.00 $718.00 $1377.00 $2397.00 | 20 | |
Metabolite of tamoxifen; may activate phagocytosis and apoptotic cell clearance pathways linked to GULP. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; activates GULP-related signaling by modulating the phosphoinositide 3-kinase pathway. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Inhibitor of Src kinase; may activate GULP by affecting signaling pathways associated with Src kinase. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynamin inhibitor; activates membrane scission during phagocytosis, potentially influencing GULP function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator/inhibitor of PKC; modulates immune responses, indirectly activating GULP-related pathways. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpain inhibitor; may activate GULP by modulating protease-dependent processes during phagocytosis. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid; anti-inflammatory agent that may activate immune responses, potentially impacting GULP function. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
Nitric oxide donor; activates immune responses and signaling, potentially impacting pathways related to GULP activation. | ||||||